What is RXRX's dilution risk score?

RXRX currently has a DilutionScore of 33/100, indicating medium dilution risk. DilutionWatch monitors RXRX SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for RXRX?

DilutionWatch tracks 25 SEC filing types for RXRX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect RXRX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For RXRX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for RXRX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for RXRX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

RXRX Dilution Risk Score: 33/100 (MEDIUM)

📊 Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

25

📊 Float Risk

17

⚠️ Warrant Exposure

40

🔄Convertible Debt—

🌦️ Dilution Forecast

☀️

Clear

No significant dilution signals

9%

💰 Capital Raise 18%

• Active ATM program with $300M remaining capacity

🔔 Track RXRX — Get forecast alerts →

💹 Market Data

Market Cap$1.77B

Shares Outstanding168.32M

FloatN/A

Cash$654.47M

Debt$723.0K

Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 226.35M shares

#1 Vanguard Group Inc 47.19M shares

#2 Blackrock Inc. 38.87M shares

#3 ARK Investment Management, LLC 37.32M shares

+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest172.30M

Days to Cover8.4

% of FloatN/A

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2022

4 INSIDER TRANSACTION Jun 22, 2026

Full SEC filing analysis available with free account →

📰 Recent News

Is Recursion Pharmaceuticals (RXRX) The Best Penny Stocks According to Billioani Yahoo Finance · Jul 09

Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market Zacks · Jul 08

Recursion Pharmaceuticals (RXRX) Is Up 8.0% After Russell Index Additions Expand Simply Wall St. · Jul 06

📋 What This Means for RXRX Shareholders

Recursion Pharmaceuticals, Inc. (RXRX) has a DilutionScore of 33/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

RXRX has an active ATM (at-the-market) program with $300.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event.

DilutionWatch tracks over 25 SEC filing types for RXRX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for RXRX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work →